| 000 | 01941 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515182654.0 | ||
| 264 | 0 | _c20090925 | |
| 008 | 200909s 0 0 eng d | ||
| 022 | _a1527-7755 | ||
| 024 | 7 |
_a10.1200/JCO.2008.20.5815 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJang, Raymond W | |
| 245 | 0 | 0 |
_aQuality-adjusted time without symptoms or toxicity analysis of adjuvant chemotherapy in non-small-cell lung cancer: an analysis of the National Cancer Institute of Canada Clinical Trials Group JBR.10 trial. _h[electronic resource] |
| 260 |
_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cSep 2009 |
||
| 300 |
_a4268-73 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 | _aCanada |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
| 650 | 0 | 4 | _aChemotherapy, Adjuvant |
| 650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aOutcome Assessment, Health Care _xmethods |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aSurveys and Questionnaires |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 |
_aVinblastine _xadministration & dosage |
| 650 | 0 | 4 | _aVinorelbine |
| 700 | 1 | _aLe Maître, Aurélie | |
| 700 | 1 | _aDing, Keyue | |
| 700 | 1 | _aWinton, Tim | |
| 700 | 1 | _aBezjak, Andrea | |
| 700 | 1 | _aSeymour, Lesley | |
| 700 | 1 | _aShepherd, Frances A | |
| 700 | 1 | _aLeighl, Natasha B | |
| 773 | 0 |
_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 27 _gno. 26 _gp. 4268-73 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1200/JCO.2008.20.5815 _zAvailable from publisher's website |
| 999 |
_c19073595 _d19073595 |
||